North America Irritable Bowel Syndrome (IBS) Diagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Diagnosis (Laboratory Tests, and Imaging Tests), and Indication (Pain and Cramping, Diarrhea, Constipation, and Alternating Constipation & Diarrhea)

Market Introduction

Irritable bowel syndrome (IBS) is defined as gastro-intestinal disorder causing discomfort in the stomach, along with wind, diarrhea, and constipation. IBS can develop after a severe session of diarrhea (gastroenteritis) caused by bacteria or a virus. People exposed to stressful events, especially in childhood, tend to have more symptoms of IBS. IBS diagnostics is done through medical history, physical exam, and imaging tests.

Market Overview and Dynamics

The North America irritable bowel syndrome (IBS) diagnostics market is expected to reach US$ 1,529.08 million by 2028 from US$ 950.83 million in 2020; it is estimated to grow at a CAGR of 6.2% from 2021 to 2028. The growth of the market is determined due to some of the key driving factors, such as increasing prevalence of irritable bowel syndrome and associated conditions and advancements in diagnostics of syndrome. On the other hand, challenges in diagnosis of IBS are likely to restraint the growth of market during the forecast years.

Key Market Segments

Based on the diagnosis, the North America irritable bowel syndrome (IBS) diagnostics market was segmented into laboratory tests and imaging tests. In 2020, the laboratory tests segment held a larger share of the market and is expected to grow at a faster rate during the coming years.

Based on indication, the North America irritable bowel syndrome (IBS) diagnostics market is segmented into pain and cramping, diarrhea, constipation, and alternating constipation & diarrhea. The pain and cramping segment held the largest share of the market in 2020 and is anticipated to register the highest CAGR in the market during the forecast period.

Major Sources and Companies Listed

A few of the primary and secondary sources associated with this report on the North America irritable bowel syndrome (IBS) diagnostics market are American Society for Gastrointestinal Endoscopy (ASGE), Centers for Disease Control and Prevention (CDC) and International Foundation for Gastrointestinal Disorders (IFFGD).

Reasons to buy the report

• Determine prospective investment areas based on a detailed trend analysis of North America irritable bowel syndrome (IBS) diagnostics market over the next years.
• Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
• Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
• Identify the major channels driving the North America irritable bowel syndrome (IBS) diagnostics market, providing a clear picture of future opportunities that will help Analyze, resulting in revenue expansion.
• Channelize resources by focusing on the ongoing programs undertaken by the different countries within the North America irritable bowel syndrome (IBS) diagnostics market.

NORTH AMERICA IRRITABLE BOWEL SYNDROME (IBS) DIAGNOSTICS MARKET SEGMENTATION

By Diagnosis

• Laboratory Tests
  • Lactose Intolerance Tests
  • Breath Test for Bacterial Overgrowth
  • Stool Tests
  • Blood Tests
• Imaging Tests
  • CT Scan or X-ray
  • Upper Endoscopy
  • Endoscopy

By Indication

• Pain and Cramping
• Diarrhea
• Constipation
• Alternating Constipation & Diarrhea

By Country

• US
• Canada
• Mexico

Company Profiles

• Commonwealth Diagnostics International
• Genova Diagnostics
• Gemelli Biotech
• Prometheus Laboratories
• Inova Diagnostics, Inc
• Biohit Oyj
• Aerodiagnostics, LLC.
• Metabolic Solutions, Inc
• Sysmex Corporation (Sysmex Europe GmbH)
• BÜHLMANN Laboratories AG

1. Commonwealth Diagnostics International
2. Genova Diagnostics
3. Gemelli Biotech
4. Prometheus Laboratories
5. Inova Diagnostics, Inc
6. Biohit Oyj
7. Aerodiagnostics, LLC.
8. Metabolic Solutions, Inc
9. Sysmex Corporation (Sysmex Europe GmbH)
10. BÜHLMANN Laboratories AG

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America irritable bowel syndrome (ibs) diagnostics market.

• Highlights key business priorities in order to assist companies to realign their business strategies.

• The key findings and recommendations highlight crucial progressive industry trends in the North America irritable bowel syndrome (ibs) diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.

• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

• Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.

• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.